The Thoracic and Cardiovascular Surgeon, Inhaltsverzeichnis Thorac Cardiovasc Surg 2009; 57(6): 329-332DOI: 10.1055/s-0029-1185731 Original Cardiovascular© Georg Thieme Verlag KG Stuttgart · New YorkLeft Ventricular Epicardial Lead Implantation via Left MinithoracotomyE. J. Lehr1 , C. Ye2 , S. Wang2 1East Carolina Heart Institute, East Carolina University, Greenville, North Carolina, United States 2Division of Cardiac Surgery, University of Alberta, Edmonton, Canada Artikel empfehlen Abstract Artikel einzeln kaufen Alle Artikel dieser Rubrik Erratum zu diesem Artikel:Erratum for: Left Ventricular Epicardial Lead Implantation via Left MinithoracotomyThorac Cardiovasc Surg 2009; 57(08): 504-504DOI: 10.1055/s-0029-1240692 Abstract Objective: The transvenous placement of left ventricular epicardial leads is limited by long procedure times, high procedural failure rates and limited sites for lead placement. Open surgical approaches are used primarily after failure of the transvenous approach but provide additional important benefits. This study assesses the surgical outcomes of left anterior minithoracotomy for the implantation of left ventricular epicardial pacing leads in cardiac resynchronization therapy. Methods: Eleven patients were referred for open left ventricular epicardial lead placement. Mean patient age was 66.2 (59–77) years. The patients had New York Heart Association class III (II–IV) heart failure, a mean left ventricular ejection fraction of 18 ± 5 % and mean QRS duration of 177 ± 29 milliseconds. Results: Left ventricular epicardial leads were successfully placed in all patients. Mean surgery time was 101 ± 33 minutes and intraoperative lead parameters were: R wave 14.5 ± 9.8 millivolts, lead threshold 1.4 ± 0.9 volts at 0.5 milliseconds, impedance 1127 ± 693 ohms. Impedance was statistically different at 40 ± 25 weeks with 571 ± 199 ohms (p = 0.033). Conclusions: Left ventricular epicardial lead implantation via left anterior minithoracotomy is safe and effective. Key words heart failure - cardiac resynchronization therapy - epicardial pacemaker lead - minimally invasive cardiac surgery Volltext Referenzen References 1 American Heart Association .Heart disease and stroke statistics – 2005 update. Dallas, Tx; American Heart Association 2004 2 MacIntyre K, Capewell S, Stewart S, Chalmers J W, Boyd J, Finlayson A et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66547 patients hospitalized between 1986 and 1995. Circulation. 2000; 102 (10) 1126-1131 3 Abraham W T, Fisher W G, Smith A L, Delurgio D B, Leon A R, Loh E et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002; 346 (24) 1845-1853 4 Higgins S L, Hummel J D, Niazi I K, Giudici M C, Worley S J, Saxon L A et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003; 42 (8) 1454-1459 5 Bristow M R, Saxon L A, Boehmer J, Krueger S, Kass D A, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004; 350 (21) 2140-2150 6 Saxon L A, Ellenbogen K A. Resynchronization therapy for the treatment of heart failure. Circulation. 2003; 108 (9) 1044-1048 7 Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001; 344 (12) 873-880 8 Young J B, Abraham W T, Smith A L, Leon A R, Lieberman R, Wilkoff B et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003; 289 (20) 2685-2694 9 Dekker A L, Phelps B, Dijkman B, van der Nagel T, van der Veen F H, Geskes G G et al. Epicardial left ventricular lead placement for cardiac resynchronization therapy: optimal pace site selection with pressure-volume loops. J Thorac Cardiovasc Surg. 2004; 127 (6) 1641-1647 10 Daoud E G, Kalbfleisch S J, Hummel J D, Weiss R, Augustini R S, Duff S B et al. Implantation techniques and chronic lead parameters of biventricular pacing dual-chamber defibrillators. J Cardiovasc Electrophysiol. 2002; 13 (10) 964-970 11 Cha Y M, Redfield M M, Shen W K, Gersh B J. Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle. Circulation. 2004; 109 (23) 2839-2843 12 Knight B P, Desai A, Coman J, Faddis M, Yong P. Long-term retention of cardiac resynchronization therapy. J Am Coll Cardiol. 2004; 44 (1) 72-77 13 Auricchio A, Ding J, Spinelli J C, Kramer A P, Salo R W, Hoersch W et al. Cardiac resynchronization therapy restores optimal atrioventricular mechanical timing in heart failure patients with ventricular conduction delay. Journal of the American College of Cardiology. 2002; 39 (7) 1163-1169 14 Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation. 1999; 99 (23) 2993-3001 Dr. MD, PhD Eric Joseph Lehr East Carolina Heart InstituteEast Carolina University 600 Moye Boulevard Greenville, NC 27834 United States Telefon: + 1 25 25 61 50 33 eMail: elehr@ualberta.ca